This is a Validated Antibody Database (VAD) review about human CD33, based on 98 published articles (read how Labome selects the articles), using CD33 antibody in all methods. It is aimed to help Labome visitors find the most suited CD33 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD33 synonym: SIGLEC-3; SIGLEC3; p67

BioLegend
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 8i
BioLegend CD33 antibody (Biolegend, 303430) was used in flow cytometry on human samples (fig 8i). Sci Rep (2021) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:100; loading ...; fig 2d
BioLegend CD33 antibody (BioLegend, 303422) was used in flow cytometry on human samples at 1:100 (fig 2d). elife (2020) ncbi
mouse monoclonal (WM53)
  • mass cytometry; human; loading ...; fig 1b, 1d, s2
BioLegend CD33 antibody (Biolegend, WM53) was used in mass cytometry on human samples (fig 1b, 1d, s2). Cell Rep (2019) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD33 antibody (BioLegend, 303303) was used in flow cytometry on human samples (fig 7a). J Exp Med (2020) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s2e
BioLegend CD33 antibody (Biolegend, 303402) was used in flow cytometry on human samples (fig s2e). Cell (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s1a
BioLegend CD33 antibody (BioLegend, 303419) was used in flow cytometry on human samples (fig s1a). Cell (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD33 antibody (BioLegend, 303416) was used in flow cytometry on human samples (fig s6a). Haematologica (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:200; loading ...; fig 3c
BioLegend CD33 antibody (Biolegend, 303407) was used in flow cytometry on human samples at 1:200 (fig 3c). elife (2019) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD33 antibody (BioLegend, P67.6) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; 1:100; loading ...
BioLegend CD33 antibody (Biolegend, HIM3-4) was used in flow cytometry on human samples at 1:100. Nature (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig s3b
BioLegend CD33 antibody (Biolegend, P67.6) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD33 antibody (Biolegend, 303404) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:400; loading ...; fig s10b
BioLegend CD33 antibody (Biolegend, 303415) was used in flow cytometry on human samples at 1:400 (fig s10b). Science (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD33 antibody (BioLegend, P67.6) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD33 antibody (BioLegend, P67.6) was used in flow cytometry on human samples (fig 3c). Oncol Lett (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; fig 7a
BioLegend CD33 antibody (BioLegend, 825601) was used in flow cytometry on human samples (fig 7a). Cell (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig s4a
BioLegend CD33 antibody (Biolegend, P67.6) was used in flow cytometry on human samples (fig s4a). J Immunol (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD33 antibody (BioLegend, 303423) was used in flow cytometry on human samples (fig 1e). J Clin Invest (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 3c
  • immunohistochemistry; human; fig 2a
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 3c) and in immunohistochemistry on human samples (fig 2a). Oncoimmunology (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 4a
In order to assess the effects of sialic acid blockade on dendritic cells, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 4a). Immunol Cell Biol (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD33 antibody (BioLegend, 303408) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi
mouse monoclonal (WM53)
  • immunohistochemistry; human; 1:300; loading ...; fig 7b
BioLegend CD33 antibody (BioLegend, 303414) was used in immunohistochemistry on human samples at 1:300 (fig 7b). J Clin Invest (2016) ncbi
mouse monoclonal (WM53)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend CD33 antibody (BioLegend, WM53) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend CD33 antibody (BioLegend, 303414) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 3
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples (fig 3). Oncotarget (2015) ncbi
mouse monoclonal (WM53)
  • other; human; fig 2
  • flow cytometry; human; fig 2
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, BioLegend CD33 antibody (Biolegend, WM53) was used in other on human samples (fig 2) and in flow cytometry on human samples (fig 2). Analyst (2016) ncbi
mouse monoclonal (WM53)
  • blocking or activating experiments; human; loading ...; fig 2c
In order to investigate cross-talk between Alzheimer loci, BioLegend CD33 antibody (BioLegend, WM53) was used in blocking or activating experiments on human samples (fig 2c). Nat Neurosci (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 1
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend CD33 antibody (BioLegend, WM-53) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples . Immunology (2014) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD33 antibody (Biolegend, WM53) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BioLegend CD33 antibody (BioLegend, WM-53) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
Invitrogen
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; loading ...; fig 4b
Invitrogen CD33 antibody (eBioscience, 17-0338-41) was used in flow cytometry on human samples (fig 4b). Stem Cell Reports (2020) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; loading ...; fig 6
Invitrogen CD33 antibody (eBioscience, 12-0338-41) was used in flow cytometry on human samples (fig 6). Gastroenterol Res Pract (2019) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; fig s7f
Invitrogen CD33 antibody (eBiosciences, 45-0338-42) was used in flow cytometry on human samples (fig s7f). Cell (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s2
Invitrogen CD33 antibody (eBiosciences, WM-53) was used in flow cytometry on human samples (fig s2). Nat Commun (2017) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; 1:25; loading ...; fig 7a
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Invitrogen CD33 antibody (eBiosciences, HIM3-4) was used in flow cytometry on human samples at 1:25 (fig 7a). Cell Transplant (2017) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; fig 1
Invitrogen CD33 antibody (eBiosciencs, 12-0338) was used in flow cytometry on human samples (fig 1). Nat Commun (2016) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; fig 5
Invitrogen CD33 antibody (eBioscience, 25-0338-42) was used in flow cytometry on human samples (fig 5). Stem Cell Reports (2016) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; fig s1
In order to describe a highly sensitive microfluidic assay to detect acute myeloid leukemia, Invitrogen CD33 antibody (Thermo Scientific, HIM3-4) was used in flow cytometry on human samples (fig s1). Analyst (2016) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; mouse; loading ...; fig s2e
In order to assess the effects of allosteric inhibitors on different mutant forms of isocitrate dehydrogenase 1 in leukemia, Invitrogen CD33 antibody (eBioscience, WM53) was used in flow cytometry on mouse samples (fig s2e). Nat Chem Biol (2015) ncbi
mouse monoclonal (WM-53 (WM53))
  • flow cytometry; human; fig s3
In order to determine the competitive advantage for human hematopoietic stem cells in vivo provided by CCND1-CDK4-mediated cell cycle progression, Invitrogen CD33 antibody (eBioscience, WM-53) was used in flow cytometry on human samples (fig s3). J Exp Med (2015) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; mouse; fig s3
Invitrogen CD33 antibody (eBioscience, 11-0339-42) was used in flow cytometry on mouse samples (fig s3). Stem Cell Res (2014) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human
Invitrogen CD33 antibody (eBiosience, HIM3-4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (P67.6)
  • other; human; fig 4b
Santa Cruz Biotechnology CD33 antibody (Santa-Cruz Biotechnology, sc-19660) was used in other on human samples (fig 4b). Sci Rep (2021) ncbi
mouse monoclonal (6C5/2)
  • western blot; mouse; 1:200; fig 4
Santa Cruz Biotechnology CD33 antibody (Santa Cruz, sc-53199) was used in western blot on mouse samples at 1:200 (fig 4). PLoS ONE (2014) ncbi
Abcam
domestic rabbit monoclonal (SP266)
  • immunohistochemistry; human; loading ...; fig 1c
Abcam CD33 antibody (Abcam, ab199432) was used in immunohistochemistry on human samples (fig 1c). Front Immunol (2021) ncbi
domestic rabbit monoclonal (SP266)
  • immunohistochemistry - paraffin section; human; loading ...; fig 6b
Abcam CD33 antibody (Abcam, ab199432) was used in immunohistochemistry - paraffin section on human samples (fig 6b). Int J Cancer (2018) ncbi
Miltenyi Biotec
human monoclonal (REA775)
  • flow cytometry; human; loading ...; fig 4c
Miltenyi Biotec CD33 antibody (Miltenyi Biotec, REA775) was used in flow cytometry on human samples (fig 4c). Cell Death Dis (2019) ncbi
Beckman Coulter
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; loading ...; fig 1b
Beckman Coulter CD33 antibody (Beckman, PN A70198) was used in flow cytometry on human samples (fig 1b). BMC Infect Dis (2019) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human
Beckman Coulter CD33 antibody (Beckman Coulter, A54824) was used in flow cytometry on human samples . Leukemia (2019) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; loading ...; fig s7c
Beckman Coulter CD33 antibody (Beckman Coulter, A54824) was used in flow cytometry on human samples (fig s7c). Cell (2017) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; 1:50; loading ...; fig 7a
In order to explore the role of thrombopoietin signaling in the human primitive hematopoietic stem cell compartment, Beckman Coulter CD33 antibody (Beckman Coulter, D3HL60.251) was used in flow cytometry on human samples at 1:50 (fig 7a). Cell Transplant (2017) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; 1:100; fig s1c
Beckman Coulter CD33 antibody (Beckman Coulter, PNIM2647U) was used in flow cytometry on human samples at 1:100 (fig s1c). Nature (2016) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human
In order to study disruption of the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity due to immunomodulatory drugs, Beckman Coulter CD33 antibody (Beckman Coulter, D3HL60.251) was used in flow cytometry on human samples . Nat Med (2016) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; tbl 4
In order to discuss how to diagnosis hematolymphoid neoplasms using flow cytometry, Beckman Coulter CD33 antibody (Beckman Coulter, D3HL60.251) was used in flow cytometry on human samples (tbl 4). Cytometry B Clin Cytom (2015) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human
Beckman Coulter CD33 antibody (Beckman Coulter, D3HL60-251) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human; fig 1
Beckman Coulter CD33 antibody (Beckman Coulter, A54824) was used in flow cytometry on human samples (fig 1). Cytometry B Clin Cytom (2014) ncbi
mouse monoclonal (D3HL60.251)
  • flow cytometry; human
In order to identify the mesenchymal markers on human adipose stem/progenitor cells, Beckman Coulter CD33 antibody (Beckman, IM2647U) was used in flow cytometry on human samples . Cytometry A (2013) ncbi
BD Biosciences
mouse monoclonal (WM53)
  • flow cytometry; human; fig s1
BD Biosciences CD33 antibody (BD, WM53) was used in flow cytometry on human samples (fig s1). Mol Ther Methods Clin Dev (2022) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:100; loading ...; fig e3d
BD Biosciences CD33 antibody (BD, 561816) was used in flow cytometry on human samples at 1:100 (fig e3d). Nature (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s2a
BD Biosciences CD33 antibody (BD Biosciences, 562492) was used in flow cytometry on human samples (fig s2a). Immunity (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:5; loading ...; fig 1g
BD Biosciences CD33 antibody (BD, WM-53) was used in flow cytometry on human samples at 1:5 (fig 1g). Mol Cell Biol (2019) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; 1:5; loading ...; fig 1j
BD Biosciences CD33 antibody (BD, 555626) was used in flow cytometry on human samples at 1:5 (fig 1j). Mol Cell Biol (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:40; loading ...; fig 5k, s22c
BD Biosciences CD33 antibody (BD Biosciences, 561816) was used in flow cytometry on human samples at 1:40 (fig 5k, s22c). Nat Commun (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; mouse; loading ...
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on mouse samples . Nature (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig s8
BD Biosciences CD33 antibody (BD Pharmingen, WM53) was used in flow cytometry on human samples (fig s8). Nat Commun (2019) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples (fig 2a). Cancer (2019) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig 1b
BD Biosciences CD33 antibody (BD Bioscience, 340679) was used in flow cytometry on human samples (fig 1b). J Clin Invest (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 5e
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples (fig 5e). Mol Ther Methods Clin Dev (2018) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences CD33 antibody (BD, 347787) was used in flow cytometry on human samples (fig s5a). Nat Med (2018) ncbi
mouse monoclonal (WM53)
  • flow cytometry; mouse; loading ...; fig 3b
BD Biosciences CD33 antibody (BD Biosciences, 551378) was used in flow cytometry on mouse samples (fig 3b). Cell Stem Cell (2017) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD33 antibody (BD Biosciences, P67.6) was used in flow cytometry on human samples (fig 1c). Nature (2017) ncbi
mouse monoclonal (WM53)
  • mass cytometry; human; loading ...; fig 1h
  • flow cytometry; human
In order to map the lineage of human dendritic cells, BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences CD33 antibody (BD Biosciences, 551378) was used in flow cytometry on human samples (fig 6a). Mol Ther Methods Clin Dev (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD33 antibody (Becton Dickinson, WM53) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; mouse; loading ...; fig s3
BD Biosciences CD33 antibody (BD Biosciences, 551378) was used in flow cytometry on mouse samples (fig s3). Nat Commun (2017) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; mouse; loading ...; fig s4
BD Biosciences CD33 antibody (BD Biosciences, 555626) was used in flow cytometry on mouse samples (fig s4). Nat Commun (2017) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...
BD Biosciences CD33 antibody (BD Biosciences, 347787) was used in flow cytometry on human samples . Oncoimmunology (2016) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; loading ...; fig s12e
BD Biosciences CD33 antibody (BD Biosciences, HIM3-4) was used in flow cytometry on human samples (fig s12e). J Clin Invest (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig e6b
In order to report preclinical studies using a CRISPR-based methodology to target hematopoietic stem cells to treat beta-haemoglobinopathies, BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples (fig e6b). Nature (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; tbl 3
In order to optimize a method to generate granulocyte lineage-committed progenitors from umbilical cord blood samples, BD Biosciences CD33 antibody (Becton Dickinson, WM53) was used in flow cytometry on human samples (tbl 3). N Biotechnol (2017) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; 1:1000
BD Biosciences CD33 antibody (BD Biosciences, 340680) was used in flow cytometry on human samples at 1:1000. Oncol Lett (2016) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; 1:100; fig 1j
In order to investigate the impact of a cancer-specific MUC1 glycoform, BD Biosciences CD33 antibody (BD, P67.6) was used in flow cytometry on human samples at 1:100 (fig 1j). Nat Immunol (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD33 antibody (BD Pharmingen, WM53) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 3b
In order to study the function of desmoglein-2 and generate knockout mice, BD Biosciences CD33 antibody (BD, WM53) was used in flow cytometry on human samples (fig 3b). Angiogenesis (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:25; fig 1b
In order to develop and characterize a humanized ossicle xenotransplantation approach, BD Biosciences CD33 antibody (BD, WM53) was used in flow cytometry on human samples at 1:25 (fig 1b). Nat Med (2016) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; 1:100; loading ...
In order to study how retinoic acid-induced HOXA gene expression controls hematopoietic stem/progenitor cells fate, identify, and function, BD Biosciences CD33 antibody (BD, 561816) was used in flow cytometry on human samples at 1:100. Nat Cell Biol (2016) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD33 antibody (BD, 347787) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; loading ...; fig 4a
In order to characterize oligopotent progenitors from the fetal liver, BD Biosciences CD33 antibody (BD, 340474) was used in flow cytometry on human samples (fig 4a). Science (2016) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; fig s4
BD Biosciences CD33 antibody (BD Biosciences, 333946) was used in flow cytometry on human samples (fig s4). Nature (2015) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; tbl 2
BD Biosciences CD33 antibody (BD Biosciences, 555626) was used in flow cytometry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (HIM3-4)
  • flow cytometry; human; fig 1e
BD Biosciences CD33 antibody (BD Biosciences, HIM3-4) was used in flow cytometry on human samples (fig 1e). Cytotherapy (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
In order to generate three different polarized macrophage and assess their immune function in an air-blood barrier co-culture, BD Biosciences CD33 antibody (BD Biosciences, 551378) was used in flow cytometry on human samples . J Tissue Eng Regen Med (2017) ncbi
mouse monoclonal (P67.6)
  • flow cytometry; human; tbl 1
BD Biosciences CD33 antibody (BD Biosciences, P67.6) was used in flow cytometry on human samples (tbl 1). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BD Biosciences CD33 antibody (BD, 555450) was used in flow cytometry on human samples . Blood Cancer J (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 2
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
In order to compared leukocyte proportions and absolute counts using reference real-time methods with a novel assay that allows long-term cryopreservation of fixed leukocytes for later counting, BD Biosciences CD33 antibody (BD, 551378) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; fig 4
BD Biosciences CD33 antibody (BD Biosciences, WM53) was used in flow cytometry on human samples (fig 4). Cancer Discov (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD33 antibody (BD, WM53) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (WM53)
  • flow cytometry; human
BD Biosciences CD33 antibody (BD Pharmingen, WM53) was used in flow cytometry on human samples . Genes Dev (2009) ncbi
Articles Reviewed
  1. Poletto E, Colella P, Pimentel Vera L, Khan S, Tomatsu S, Baldo G, et al. Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation. Mol Ther Methods Clin Dev. 2022;25:392-409 pubmed publisher
  2. Li B, Lian M, Li Y, Qian Q, Zhang J, Liu Q, et al. Myeloid-Derived Suppressive Cells Deficient in Liver X Receptor α Protected From Autoimmune Hepatitis. Front Immunol. 2021;12:732102 pubmed publisher
  3. Wißfeld J, Mathews M, Mossad O, Picardi P, Cinti A, Redaelli L, et al. Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia. Sci Rep. 2021;11:13462 pubmed publisher
  4. Wang Y, Mohseni M, Grauel A, Diez J, Guan W, Liang S, et al. SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms. Sci Rep. 2021;11:1399 pubmed publisher
  5. Danzer H, Glaesner J, Baerenwaldt A, Reitinger C, Lux A, Heger L, et al. Human Fcγ-receptor IIb modulates pathogen-specific versus self-reactive antibody responses in lyme arthritis. elife. 2020;9: pubmed publisher
  6. Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et al. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem Cell Reports. 2020;14:49-59 pubmed publisher
  7. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  8. Calvanese V, Nguyen A, Bolan T, Vavilina A, Su T, Lee L, et al. MLLT3 governs human haematopoietic stem-cell self-renewal and engraftment. Nature. 2019;576:281-286 pubmed publisher
  9. Guo P, Li L, Li W, Zhao J, Hu F, Zhang F, et al. The clinical significance of myeloid-derived suppressor cells in dengue fever patients. BMC Infect Dis. 2019;19:926 pubmed publisher
  10. Yan D, Wang J, Sun H, Zamani A, Zhang H, Chen W, et al. TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis. J Exp Med. 2020;217: pubmed publisher
  11. Dutertre C, Becht E, Irac S, Khalilnezhad A, Narang V, Khalilnezhad S, et al. Single-Cell Analysis of Human Mononuclear Phagocytes Reveals Subset-Defining Markers and Identifies Circulating Inflammatory Dendritic Cells. Immunity. 2019;51:573-589.e8 pubmed publisher
  12. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  13. Jordan S, Tung N, Casanova Acebes M, Chang C, Cantoni C, Zhang D, et al. Dietary Intake Regulates the Circulating Inflammatory Monocyte Pool. Cell. 2019;178:1102-1114.e17 pubmed publisher
  14. Nasri M, Ritter M, Mir P, Dannenmann B, Aghaallaei N, Amend D, et al. CRISPR/Cas9 mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients. Haematologica. 2019;: pubmed publisher
  15. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  16. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed publisher
  17. van Bergeijk P, Seneviratne U, Aparicio Prat E, Stanton R, Hasson S. SRSF1 and PTBP1 are trans-acting factors that suppress the formation of a CD33 splicing isoform linked to Alzheimer's disease risk. Mol Cell Biol. 2019;: pubmed publisher
  18. Xia Y, Gao Y, Wang B, Zhang H, Zhang Q. Optimizing the Method of Cell Separation from Bile of Patients with Cholangiocarcinoma for Flow Cytometry. Gastroenterol Res Pract. 2019;2019:5436961 pubmed publisher
  19. Pellin D, Loperfido M, Baricordi C, Wolock S, Montepeloso A, Weinberg O, et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun. 2019;10:2395 pubmed publisher
  20. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  21. Veglia F, Tyurin V, Blasi M, De Leo A, Kossenkov A, Donthireddy L, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. 2019;569:73-78 pubmed publisher
  22. Pavel Dinu M, Wiebking V, Dejene B, Srifa W, Mantri S, Nicolas C, et al. Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nat Commun. 2019;10:1634 pubmed publisher
  23. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  24. Deng M, Gui X, Kim J, Xie L, Chen W, Li Z, et al. LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration. Nature. 2018;562:605-609 pubmed publisher
  25. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  26. Haubner S, Perna F, Köhnke T, Schmidt C, Berman S, Augsberger C, et al. Coexpression profile of leukemic stem cell markers for combinatorial targeted therapy in AML. Leukemia. 2019;33:64-74 pubmed publisher
  27. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  28. Honeycutt J, Liao B, Nixon C, Cleary R, Thayer W, Birath S, et al. T cells establish and maintain CNS viral infection in HIV-infected humanized mice. J Clin Invest. 2018;128:2862-2876 pubmed publisher
  29. Li C, Psatha N, Wang H, Singh M, Samal H, Zhang W, et al. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. Mol Ther Methods Clin Dev. 2018;9:142-152 pubmed publisher
  30. Muhar M, Ebert A, Neumann T, Umkehrer C, Jude J, Wieshofer C, et al. SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis. Science. 2018;360:800-805 pubmed publisher
  31. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  32. Zhang B, Nguyen L, Li L, Zhao D, Kumar B, Wu H, et al. Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia. Nat Med. 2018;24:450-462 pubmed publisher
  33. Qu S, Xue H, Dong X, Lin D, Wu R, Nabavi N, et al. Aneustat (OMN54) has aerobic glycolysis-inhibitory activity and also immunomodulatory activity as indicated by a first-generation PDX prostate cancer model. Int J Cancer. 2018;143:419-429 pubmed publisher
  34. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
  35. Tavazoie M, Pollack I, Tanqueco R, Ostendorf B, Reis B, Gonsalves F, et al. LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer. Cell. 2018;172:825-840.e18 pubmed publisher
  36. Wu X, Dao Thi V, Huang Y, Billerbeck E, Saha D, Hoffmann H, et al. Intrinsic Immunity Shapes Viral Resistance of Stem Cells. Cell. 2018;172:423-438.e25 pubmed publisher
  37. Schwartz J, Ma J, Lamprecht T, Walsh M, Wang S, Bryant V, et al. The genomic landscape of pediatric myelodysplastic syndromes. Nat Commun. 2017;8:1557 pubmed publisher
  38. Gaidt M, Ebert T, Chauhan D, Ramshorn K, Pinci F, Zuber S, et al. The DNA Inflammasome in Human Myeloid Cells Is Initiated by a STING-Cell Death Program Upstream of NLRP3. Cell. 2017;171:1110-1124.e18 pubmed publisher
  39. Tothova Z, Krill Burger J, Popova K, Landers C, Sievers Q, Yudovich D, et al. Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia. Cell Stem Cell. 2017;21:547-555.e8 pubmed publisher
  40. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  41. Chang A, Dao T, Gejman R, Jarvis C, Scott A, Dubrovsky L, et al. A therapeutic T cell receptor mimic antibody targets tumor-associated PRAME peptide/HLA-I antigens. J Clin Invest. 2017;127:2705-2718 pubmed publisher
  42. Sugimura R, Jha D, Han A, Soria Valles C, da Rocha E, Lu Y, et al. Haematopoietic stem and progenitor cells from human pluripotent stem cells. Nature. 2017;545:432-438 pubmed publisher
  43. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  44. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  45. Chang K, Smith S, Sullivan T, Chen K, Zhou Q, West J, et al. Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells. Mol Ther Methods Clin Dev. 2017;4:137-148 pubmed publisher
  46. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  47. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  48. Pardi N, Secreto A, Shan X, Debonera F, Glover J, Yi Y, et al. Administration of nucleoside-modified mRNA encoding broadly neutralizing antibody protects humanized mice from HIV-1 challenge. Nat Commun. 2017;8:14630 pubmed publisher
  49. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  50. Matsuoka Y, Takahashi M, Sumide K, Kawamura H, Nakatsuka R, Fujioka T, et al. CD34 Antigen and the MPL Receptor Expression Defines a Novel Class of Human Cord Blood-Derived Primitive Hematopoietic Stem Cells. Cell Transplant. 2017;26:1043-1058 pubmed publisher
  51. Ng S, Mitchell A, Kennedy J, Chen W, McLeod J, Ibrahimova N, et al. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature. 2016;540:433-437 pubmed publisher
  52. Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed publisher
  53. Sherbenou D, Aftab B, Su Y, Behrens C, Wiita A, Logan A, et al. Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells. J Clin Invest. 2016;126:4640-4653 pubmed publisher
  54. Dever D, Bak R, Reinisch A, Camarena J, Washington G, Nicolas C, et al. CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 2016;539:384-389 pubmed publisher
  55. Casamayor Genescà A, Pla A, Oliver Vila I, Pujals Fonts N, Marín Gallén S, Caminal M, et al. Clinical-scale expansion of CD34+ cord blood cells amplifies committed progenitors and rapid scid repopulation cells. N Biotechnol. 2017;35:19-29 pubmed publisher
  56. Zahran A, Aly S, Altayeb H, Ali A. Circulating endothelial cells and their progenitors in acute myeloid leukemia. Oncol Lett. 2016;12:1965-1970 pubmed
  57. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  58. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  59. Jacoby E, Nguyen S, Fountaine T, Welp K, Gryder B, Qin H, et al. CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity. Nat Commun. 2016;7:12320 pubmed publisher
  60. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  61. Ding L, Hayes M, Photenhauer A, Eaton K, Li Q, Ocadiz Ruiz R, et al. Schlafen 4-expressing myeloid-derived suppressor cells are induced during murine gastric metaplasia. J Clin Invest. 2016;126:2867-80 pubmed publisher
  62. Ebert L, Tan L, Johan M, Min K, Cockshell M, Parham K, et al. A non-canonical role for desmoglein-2 in endothelial cells: implications for neoangiogenesis. Angiogenesis. 2016;19:463-86 pubmed publisher
  63. Eichner R, Heider M, Fernández Sáiz V, van Bebber F, Garz A, Lemeer S, et al. Immunomodulatory drugs disrupt the cereblon-CD147-MCT1 axis to exert antitumor activity and teratogenicity. Nat Med. 2016;22:735-43 pubmed publisher
  64. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  65. Dou D, Calvanese V, Sierra M, Nguyen A, Minasian A, Saarikoski P, et al. Medial HOXA genes demarcate haematopoietic stem cell fate during human development. Nat Cell Biol. 2016;18:595-606 pubmed publisher
  66. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  67. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  68. Kyttälä A, Moraghebi R, Valensisi C, Kettunen J, Andrus C, Pasumarthy K, et al. Genetic Variability Overrides the Impact of Parental Cell Type and Determines iPSC Differentiation Potential. Stem Cell Reports. 2016;6:200-12 pubmed publisher
  69. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  70. Valletta S, Dolatshad H, Bartenstein M, Yip B, Bello E, Gordon S, et al. ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts. Oncotarget. 2015;6:44061-71 pubmed publisher
  71. Notta F, Zandi S, Takayama N, Dobson S, Gan O, Wilson G, et al. Distinct routes of lineage development reshape the human blood hierarchy across ontogeny. Science. 2016;351:aab2116 pubmed publisher
  72. Jackson J, Taylor J, Witek M, Hunsucker S, Waugh J, Fedoriw Y, et al. Microfluidics for the detection of minimal residual disease in acute myeloid leukemia patients using circulating leukemic cells selected from blood. Analyst. 2016;141:640-51 pubmed publisher
  73. Okoye Okafor U, Bartholdy B, Cartier J, Gao E, Pietrak B, Rendina A, et al. New IDH1 mutant inhibitors for treatment of acute myeloid leukemia. Nat Chem Biol. 2015;11:878-86 pubmed publisher
  74. Chan G, White C, Winn P, Cimpean M, Replogle J, Glick L, et al. CD33 modulates TREM2: convergence of Alzheimer loci. Nat Neurosci. 2015;18:1556-8 pubmed publisher
  75. Fong C, Gilan O, Lam E, Rubin A, Ftouni S, Tyler D, et al. BET inhibitor resistance emerges from leukaemia stem cells. Nature. 2015;525:538-42 pubmed publisher
  76. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  77. Jobin C, Cloutier M, Simard C, Néron S. Heterogeneity of in vitro-cultured CD34+ cells isolated from peripheral blood. Cytotherapy. 2015;17:1472-84 pubmed publisher
  78. Mende N, Kuchen E, Lesche M, Grinenko T, Kokkaliaris K, Hanenberg H, et al. CCND1-CDK4-mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo. J Exp Med. 2015;212:1171-83 pubmed publisher
  79. Kasper J, Hermanns M, Unger R, Kirkpatrick C. A responsive human triple-culture model of the air-blood barrier: incorporation of different macrophage phenotypes. J Tissue Eng Regen Med. 2017;11:1285-1297 pubmed publisher
  80. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  81. Fromm J, Tagliente D, Shaver A, Neppalli V, Craig F. Case study interpretation: Report from the ICCS Annual Meeting, Seattle, 2014. Cytometry B Clin Cytom. 2015;88:413-24 pubmed publisher
  82. Boerman G, van Ostaijen Ten Dam M, Kraal K, Santos S, Ball L, Lankester A, et al. Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells. Cancer Immunol Immunother. 2015;64:573-83 pubmed publisher
  83. Saland E, Boutzen H, Castellano R, Pouyet L, Griessinger E, Larrue C, et al. A robust and rapid xenograft model to assess efficacy of chemotherapeutic agents for human acute myeloid leukemia. Blood Cancer J. 2015;5:e297 pubmed publisher
  84. Du Z, Abedalthagafi M, Aizer A, McHenry A, Sun H, Bray M, et al. Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma. Oncotarget. 2015;6:4704-16 pubmed
  85. Nemes E, Kagina B, Smit E, Africa H, Steyn M, Hanekom W, et al. Differential leukocyte counting and immunophenotyping in cryopreserved ex vivo whole blood. Cytometry A. 2015;87:157-65 pubmed publisher
  86. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  87. Llosa N, Cruise M, Tam A, Wicks E, Hechenbleikner E, Taube J, et al. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov. 2015;5:43-51 pubmed publisher
  88. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  89. Wilson E, Bial J, Tarlow B, Bial G, Jensen B, Greiner D, et al. Extensive double humanization of both liver and hematopoiesis in FRGN mice. Stem Cell Res. 2014;13:404-12 pubmed publisher
  90. Vogel K, Thomann S, Vogel B, Schuster P, Schmidt B. Both plasmacytoid dendritic cells and monocytes stimulate natural killer cells early during human herpes simplex virus type 1 infections. Immunology. 2014;143:588-600 pubmed publisher
  91. Lepore M, de Lalla C, Gundimeda S, Gsellinger H, Consonni M, Garavaglia C, et al. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias. J Exp Med. 2014;211:1363-77 pubmed publisher
  92. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  93. Xu Z, Dong Y, Wang H, Culley D, Marcantonio E, Crosby G, et al. Peripheral surgical wounding and age-dependent neuroinflammation in mice. PLoS ONE. 2014;9:e96752 pubmed publisher
  94. Cartellieri M, Koristka S, Arndt C, Feldmann A, Stamova S, von Bonin M, et al. A novel ex vivo isolation and expansion procedure for chimeric antigen receptor engrafted human T cells. PLoS ONE. 2014;9:e93745 pubmed publisher
  95. Martin R, Saleem S, Folgosa L, Zellner H, Damle S, Nguyen G, et al. Mast cell histamine promotes the immunoregulatory activity of myeloid-derived suppressor cells. J Leukoc Biol. 2014;96:151-9 pubmed publisher
  96. Greig B, Stetler Stevenson M, Lea J. Stabilization media increases recovery in paucicellular cerebrospinal fluid specimens submitted for flow cytometry testing. Cytometry B Clin Cytom. 2014;86:135-8 pubmed publisher
  97. Zimmerlin L, Donnenberg V, Rubin J, Donnenberg A. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A. 2013;83:134-40 pubmed publisher
  98. Doulatov S, Notta F, Rice K, Howell L, Zelent A, Licht J, et al. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev. 2009;23:2076-87 pubmed publisher